269 related articles for article (PubMed ID: 34831269)
1. In Silico Model Estimates the Clinical Trial Outcome of Cancer Vaccines.
Lőrincz O; Tóth J; Molnár L; Miklós I; Pántya K; Megyesi M; Somogyi E; Csiszovszki Z; Tőke ER
Cells; 2021 Nov; 10(11):. PubMed ID: 34831269
[TBL] [Abstract][Full Text] [Related]
2. A novel multi-epitope peptide vaccine against cancer: an in silico approach.
Nezafat N; Ghasemi Y; Javadi G; Khoshnoud MJ; Omidinia E
J Theor Biol; 2014 May; 349():121-34. PubMed ID: 24512916
[TBL] [Abstract][Full Text] [Related]
3. In silico analyses of Wilms׳ tumor protein to designing a novel multi-epitope DNA vaccine against cancer.
Khalili S; Rahbar MR; Dezfulian MH; Jahangiri A
J Theor Biol; 2015 Aug; 379():66-78. PubMed ID: 25936349
[TBL] [Abstract][Full Text] [Related]
4. Sequence-based in silico analysis of well studied hepatitis C virus epitopes and their variants in other genotypes (particularly genotype 5a) against South African human leukocyte antigen backgrounds.
Prabdial-Sing N; Puren AJ; Bowyer SM
BMC Immunol; 2012 Dec; 13():67. PubMed ID: 23227878
[TBL] [Abstract][Full Text] [Related]
5. Identification of HLA-A*03, A*11 and B*07-restricted melanoma-associated peptides that are immunogenic in vivo by vaccine-induced immune response (VIIR) analysis.
Reynolds SR; Celis E; Sette A; Oratz R; Shapiro RL; Johnston D; Fotino M; Bystryn JC
J Immunol Methods; 2000 Oct; 244(1-2):59-67. PubMed ID: 11033019
[TBL] [Abstract][Full Text] [Related]
6. Unraveling the role of preexisting immunity in prostate cancer patients vaccinated with a HER-2/neu hybrid peptide.
Voutsas IF; Anastasopoulou EA; Tzonis P; Papamichail M; Perez SA; Baxevanis CN
J Immunother Cancer; 2016; 4():75. PubMed ID: 27891225
[TBL] [Abstract][Full Text] [Related]
7. Cancer vaccine strategies: translation from mice to human clinical trials.
Berzofsky JA; Terabe M; Trepel JB; Pastan I; Stroncek DF; Morris JC; Wood LV
Cancer Immunol Immunother; 2018 Dec; 67(12):1863-1869. PubMed ID: 29143114
[TBL] [Abstract][Full Text] [Related]
8. Reverse Vaccinology Approach in Constructing a Multi-Epitope Vaccine Against Cancer-Testis Antigens Expressed in Non-Small Cell Lung Cancer.
Herrera LRM
Asian Pac J Cancer Prev; 2021 May; 22(5):1495-1506. PubMed ID: 34048178
[TBL] [Abstract][Full Text] [Related]
9. Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigens.
Mortier MC; Jongert E; Mettens P; Ruelle JL
BMC Immunol; 2015 Oct; 16():63. PubMed ID: 26493839
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic T-lymphocyte elicited therapeutic vaccine candidate targeting cancer against MAGE-A11 carcinogenic protein.
Kumar N; Sood D; Gupta A; Jha NK; Jain P; Chandra R
Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33169789
[TBL] [Abstract][Full Text] [Related]
11. Myeloid dendritic cells loaded with dendritic tandem multiple antigenic telomerase reverse transcriptase (hTERT) epitope peptides: a potentially promising tumor vaccine.
Niu BL; Du HM; Shen HP; Lian ZR; Li JZ; Lai X; Wei SD; Zou LQ; Gong JP
Vaccine; 2012 May; 30(23):3395-404. PubMed ID: 22480929
[TBL] [Abstract][Full Text] [Related]
12. In Silico-Guided Sequence Modification of Epitopes in Cancer Vaccine Development.
Hoo WPY; Siak PY; In LLA
Methods Mol Biol; 2020; 2131():213-228. PubMed ID: 32162256
[TBL] [Abstract][Full Text] [Related]
13. In vitro and ex vivo evaluation of a multi-epitope heparinase vaccine for various malignancies.
Tang XD; Guo SL; Wang GZ; Li N; Wu YY; Fang DC; Fan YH; Yang SM
Cancer Sci; 2014 Jan; 105(1):9-17. PubMed ID: 24152338
[TBL] [Abstract][Full Text] [Related]
14. Identification and Immune Assessment of T Cell Epitopes in Five
Kotraiah V; Phares TW; Terry FE; Hindocha P; Silk SE; Nielsen CM; Moise L; Tucker KD; Ashfield R; Martin WD; De Groot AS; Draper SJ; Gutierrez GM; Noe AR
Front Immunol; 2021; 12():690348. PubMed ID: 34305923
[TBL] [Abstract][Full Text] [Related]
15. A Proteome-Wide Immunoinformatics Tool to Accelerate T-Cell Epitope Discovery and Vaccine Design in the Context of Emerging Infectious Diseases: An Ethnicity-Oriented Approach.
Oyarzun P; Kashyap M; Fica V; Salas-Burgos A; Gonzalez-Galarza FF; McCabe A; Jones AR; Middleton D; Kobe B
Front Immunol; 2021; 12():598778. PubMed ID: 33717077
[TBL] [Abstract][Full Text] [Related]
16. DNA vaccines encoding altered peptide ligands for SSX2 enhance epitope-specific CD8+ T-cell immune responses.
Smith HA; Rekoske BT; McNeel DG
Vaccine; 2014 Mar; 32(15):1707-15. PubMed ID: 24492013
[TBL] [Abstract][Full Text] [Related]
17. Promiscuous
Scholzen A; Richard G; Moise L; Baeten LA; Reeves PM; Martin WD; Brauns TA; Boyle CM; Raju Paul S; Bucala R; Bowen RA; Garritsen A; De Groot AS; Sluder AE; Poznansky MC
Front Immunol; 2019; 10():207. PubMed ID: 30828331
[No Abstract] [Full Text] [Related]
18. In Silico Approach in Designing a Novel Multi-Epitope Vaccine Candidate against Non-Small Cell Lung Cancer with Overexpressed G Protein-Coupled Receptor 56.
Herrera LRM
Asian Pac J Cancer Prev; 2020 Aug; 21(8):2297-2306. PubMed ID: 32856858
[TBL] [Abstract][Full Text] [Related]
19. In silico design of discontinuous peptides representative of B and T-cell epitopes from HER2-ECD as potential novel cancer peptide vaccines.
Manijeh M; Mehrnaz K; Violaine M; Hassan M; Abbas J; Mohammad R
Asian Pac J Cancer Prev; 2013; 14(10):5973-81. PubMed ID: 24289611
[TBL] [Abstract][Full Text] [Related]
20.
Schmidt J; Guillaume P; Dojcinovic D; Karbach J; Coukos G; Luescher I
J Biol Chem; 2017 Jul; 292(28):11840-11849. PubMed ID: 28536262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
